Stocksigma LogoStocksigma Logo

JFL Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 9,865 (+229.8% YoY | +788.5% QoQ) ■ EBITDA: 665 (+128.0% YoY | +217.5% QoQ) ■ EBITDA Margin (%): 6.7 (-301 bps YoY | -1212 bps QoQ) ■ PAT: 423

JFL Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

JFL Life Sciences Ltd · Outcome · 02 Nov 2026, 9:36 pm

JFL Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 9,865 (+229.8% YoY | +788.5% QoQ) ■ EBITDA: 665 (+128.0% YoY | +217.5% QoQ) ■ EBITDA Margin (%): 6.7 (-301 bps YoY | -1212 bps QoQ) ■ PAT: 423 (+114.1% YoY | +279.6% QoQ) ■ EPS (INR): 1.28 (+113.3% YoY | +276.5% QoQ)

Original exchange filing (PDF)

More announcements from JFL Life Sciences Ltd

All JFL Life Sciences Ltd announcements